Comment Submitted by Ronald J. Schott, Corporate Counsel, Environment, Safety and Health, Wyeth

Document ID: EPA-HQ-OAR-2007-0297-0042
Document Type: Public Submission
Agency: Environmental Protection Agency
Received Date: July 11 2007, at 12:48 PM Eastern Daylight Time
Date Posted: June 4 2008, at 12:00 AM Eastern Standard Time
Comment Start Date: June 12 2007, at 12:00 AM Eastern Standard Time
Comment Due Date: July 12 2007, at 11:59 PM Eastern Standard Time
Tracking Number: 806107cf
View Document:  View as format xml

Attachments:

Comment Submitted by Ronald J. Schott, Corporate Counsel, Environment, Safety and Health, Wyeth

Title:
Comment Submitted by Ronald J. Schott, Corporate Counsel, Environment, Safety and Health, Wyeth

Abstract:
Public version of comments submitted by Ronald Schott, Esq, Corporate Counsel, Wyeth on June 11, 2007.

View Attachment: View as format pdf

Related Comments

   
Total: 4
Comment submitted by B. Sachau
Public Submission    Posted: 06/18/2007     ID: EPA-HQ-OAR-2007-0297-0030

Jul 12,2007 11:59 PM ET
Comment submitted by James A. Losey, Counsel for GlaxoSmithKline (GSK)
Public Submission    Posted: 07/13/2007     ID: EPA-HQ-OAR-2007-0297-0031

Jul 12,2007 11:59 PM ET
Comment submitted by Marc Couturier, Senior Vice President, Global Business Development, Inyx, Inc.
Public Submission    Posted: 07/16/2007     ID: EPA-HQ-OAR-2007-0297-0032

Jul 12,2007 11:59 PM ET
Comment Submitted by Ronald J. Schott, Corporate Counsel, Environment, Safety and Health, Wyeth
Public Submission    Posted: 06/04/2008     ID: EPA-HQ-OAR-2007-0297-0042

Jul 12,2007 11:59 PM ET